AEVEX (AVEX) Q1 2026 earnings review
Explosive Top-Line Growth Masks Sizable Cash Burn and Peak Backlog
AEVEX delivered a blockbuster Q1, with revenue surging 307% YoY to $216.7 million, driven heavily by the EUCOM AOR Deep Strike program. Profitability followed, reversing a prior-year loss to achieve a 16.8% Adjusted EBITDA margin. However, the underlying data suggests Q1 was a peak rather than a new baseline. Funded backlog plunged by $146.5 million sequentially, and management's FY26 guidance implies a steep deceleration for the remainder of the year. Furthermore, despite reporting $21 million in net income, operating cash flow remained deeply negative, bogged down by a $71 million increase in uncollected receivables and unbilled contract assets.
🐂 Bull Case
The company proved its ability to scale profitably. Tactical Systems revenue jumped 548%, yet R&D expenses actually declined by $6.2M, allowing the segment's Adjusted EBITDA margin to flip from negative 33.5% to positive 20.2%.
The successful scaling and delivery of the EUCOM AOR Deep Strike program validates AEVEX's manufacturing capacity and solidifies its position as a reliable defense contractor.
🐻 Bear Case
Net income of $21.0 million is a mirage when compared to Operating Cash Flow of negative $10.4 million. The company is recognizing revenue much faster than it can actually collect cash from the government.
With backlog dropping 29% in a single quarter and 93% of the remaining $356.6 million expected to convert in 2026, AEVEX must win major new multi-year contracts immediately, or face a severe revenue contraction next year.
⚖️ Verdict: ⚪
Neutral. The headline growth numbers are spectacular and validate the product suite, but the sequential backlog burn, massive working capital drain, and implied Q2-Q4 deceleration suggest the most explosive growth is already in the rearview mirror.
Key Themes
Tactical Systems Segment Hypergrowth
Tactical Systems is the undisputed engine of the company, with revenue accelerating a staggering 548% YoY to $190.8 million. The growth was almost entirely driven by UAS (Unmanned Aircraft Systems) product deliveries tied to the EUCOM AOR Deep Strike program, proving the company's ability to transition from development to high-volume manufacturing.
Adoption of CompassX AI-Enabled Autonomy
Management explicitly credited sustained customer adoption of its AI-enabled autonomy solutions, specifically powered by the CompassX platform. This validates the thesis that AEVEX is successfully shifting its product mix toward high-value, next-generation mission software that aligns closely with modern defense priorities.
Aggressive Margin Expansion via Cost Control
Adjusted EBITDA margins reversed from -25.1% in Q1 2025 to 16.8% this quarter. This wasn't just a volume story; it was driven by disciplined cost control. Despite total revenues quadrupling, Research & Development expenses actually fell from $9.5 million to $3.3 million as early-stage UAS development transitioned into scaled production.
Cash Conversion Contradicts Bullish Narrative
The CFO touted 'continued progress in improving cash flow,' but the data tells a deeply concerning story. Operating Cash Flow remained negative at $(10.4) million despite $21.0 million in net income. The culprit: a massive $41.0 million spike in unbilled Contract Assets and a $30.4 million jump in Accounts Receivable. AEVEX is booking the revenue, but $71 million of it is stuck in working capital limbo.
Severe Backlog Depletion
Funded backlog plunged from $503.1 million at year-end to $356.6 million by March 31, entirely due to rapid revenue recognition on the EUCOM AOR Deep Strike program. With management projecting that 93% of the remaining backlog will convert into revenue during the rest of 2026, the pipeline is thinning out dangerously fast.
Extreme Customer and Macro Concentration
AEVEX noted that 73.9% of its funded backlog is tied directly to the U.S. Government. Management actively warned that guidance depends on the government remaining open and avoiding prolonged continuing resolutions. Any macro-level budget gridlock in Washington will immediately paralyze the company's ability to replenish its rapidly depleting backlog.
Other KPIs
Accelerating significantly. Up 126% from $8.6 million in 25Q1. Management attributed this to $3.8 million in audit/accounting fees related to their IPO process and $3.0 million in new employee-related costs. This indicates a higher structural cost baseline as a newly public entity.
Surged 51% from $79.7 million at year-end 2025. This balance sheet item represents work performed but not yet billed, creating a massive drag on liquidity. The speed at which AEVEX can invoice the DoD and convert these assets to cash will dictate whether they need to tap external financing.
Guidance
Decelerating violently. While the full-year number is large, AEVEX already booked $216.7 million in Q1. The $610 million midpoint implies the company will average just $131.1 million per quarter for Q2-Q4. This represents a ~40% sequential drop-off from the Q1 run-rate, confirming the EUCOM Deep Strike program provided a massive, non-linear bump.
Decelerating sequentially. With $36.4 million already achieved in Q1, the $91.25 million midpoint leaves only $54.85 million for the remaining three quarters (an average of ~$18.3 million per quarter). This implies Adjusted EBITDA margins will compress from 16.8% in Q1 down to roughly 13.9% for the remainder of the year as high-margin UAS volumes normalize.
Key Questions
2027 Pipeline Visibility
With 93% of your current $356 million funded backlog scheduled to convert this year, what specific major program awards are you tracking to prevent a severe revenue cliff in 2027?
Path to Positive Cash Flow
Contract assets and accounts receivable consumed $71 million in cash this quarter. Can you provide a specific timeline on when these milestones will be billed to the government and collected?
Margin Compression Drivers
Your implied Q2-Q4 guidance suggests a sharp drop in both revenue run-rate and EBITDA margins compared to Q1. Is this margin compression entirely due to fixed cost deleverage on lower volumes, or are there differing margin profiles on the remaining backlog?